Projects | SRI International

Toggle Menu

Projects

bioscience workers in a lab
SRI is conducting preclinical development of treatments for diseases such as tuberculosis, West Nile virus, hepatitis, and biodefense pathogens and toxins.
monoclonal antibodies
Novel molecular targets of several cytokines are being evaluated by SRI scientists, with the goal of designing a small-molecule drug to block responses involved in many of these inflammatory diseases.
a high-throughput fluorescence polarization assay
SRI is seeking new treatments for tuberculosis, a global health crisis.
scientist checking a batch of vaccines
SRI has patented a novel approach to vaccine delivery that is safe for pediatric use, eliminating the need for painful injections.
An SRI vaccine researcher in protective clothing and a mask
To help prepare for next-generation pandemics, SRI is partnering with Stanford University to examine vaccination responses.
hand holding a petri dish of bacterial culture up to the light
Vitamin A deficiency causes susceptibility — especially in children — to diarrhea-causing infections, which lead to millions of deaths each year. SRI is developing a probiotic that produces the vitamin.